Cytocare Inc.: The Aliso Viejo developer of...

Cytocare Inc.: The Aliso Viejo developer of products and services to treat urological disease reported a third-quarter profit of $1.5 million, or 28 cents a share, which included a onetime tax credit of $331,000. That compared to a profit of $13,561 for the same period a year earlier. Revenue was up 21%, to $4 million from $3.3 million. For the first nine months, profit totaled $3.1 million, or 58 cents a share, compared to earnings of $410,562, or 8 cents a share, for the comparable 1993 period. Nine-month revenue increased 17%, to $12.3 million from $10.5 million.